Carboplatin Injection
Regulated Product — Business License RequiredB2B and export product information for licensed and authorized business customers. Contact our team regarding bulk supply, documentation, and applicable commercial, import, and export requirements. This page is not a storefront and no purchasing, checkout, or pricing is offered here.
Product Overview
Carboplatin Injection contains carboplatin, a platinum-based chemotherapy medicine. Its labelling describes it for the treatment of ovarian cancer, small-cell lung cancer, and bladder cancer, interfering with cancer-cell DNA to hinder their growth. It is used first-line for advanced ovarian cancer (combined with paclitaxel) and for recurrent ovarian cancer; for non-small cell and small-cell lung cancer (often with etoposide or paclitaxel); to shrink bladder tumours before surgery; and off-label for breast and testicular cancer. It is an intravenous injection administered only by a healthcare expert.
Product Information
The following description reflects information associated with this product’s labelling. It has not been independently clinically verified by SDO Pharma and is provided for business and product-identification purposes only. It is not medical advice and does not replace the manufacturer’s official prescribing information.
Described Uses
- Described for the first-line treatment of advanced ovarian cancer (combined with paclitaxel) and for recurrent ovarian cancer
- Described for non-small cell lung cancer and small-cell lung cancer, often combined with etoposide or paclitaxel
- Described for shrinking bladder tumours before surgery; also used off-label for breast cancer and testicular cancer
- Described as interfering with cancer-cell DNA to slow the growth of cancer cells
Described Dosage & Administration
- An intravenous injection given under the supervision of a doctor; it should not be self-administered
- The doctor recommends the dosage depending on kidney function, overall body symptoms, and lab test results
- A dose should not be skipped or exceeded, as this may lead to serious side effects
Described Side Effects
Commonly described side effects include:
- Fever, sore throat, and chills
- Unusual bleeding
- Dark urine
- Reduced red blood cell and white blood cell counts
The symptoms are described as not lasting long; the doctor should be informed if they are bothersome, and immediately if allergic reactions such as itching, skin rash, or difficulty breathing occur.
Precautions
- Regular blood tests, along with liver and heart monitoring and a uric acid level test, are recommended
- Both men and women must use contraception during treatment to avoid pregnancy
- Pregnant women or breastfeeding mothers must consult a doctor before starting the medicine
This summary is provided for informational purposes only and does not replace the manufacturer’s official product labelling or professional medical advice.
B2B, Import & Export Enquiries
SDO Pharma supports business enquiries for pharmaceutical and healthcare products, including bulk and export supply, subject to applicable licensing, regulatory, import, and export requirements. Requirements vary according to the destination market and the nature of the transaction.
We do not claim that this product is available for import into every country, and we do not claim FDA, UAE, EU, or other specific regulatory approval unless independently verified. Applicable documentation — including a valid Drug License, tax registration, and Importer Exporter Code (IEC) where relevant — is discussed directly with our team as part of the enquiry process. This is a regulated / prescription-status product supplied only to licensed and authorized business customers; SDO Pharma does not sell it directly to individual patients or consumers. See our Regulated Products Policy.
Request Product Information
Interested in this product for your business? Submit your enquiry and our team will contact you regarding bulk supply, documentation, and applicable requirements.
Frequently Asked Questions
Per its labelling it contains carboplatin and is used for the treatment of ovarian cancer, small-cell lung cancer, and bladder cancer, among other uses. SDO Pharma has not independently verified the manufacturer’s claims and does not claim any specific regulatory approval unless independently confirmed.
Its labelling describes it as an intravenous injection given only by a healthcare expert under a doctor’s supervision, with the dosage based on kidney function and lab results.
Licensed and authorized business customers can submit the product enquiry form above or contact our team directly. Product availability, documentation, and supply arrangements are confirmed per enquiry.
Availability depends on the destination market’s regulatory requirements and cannot be confirmed without a direct enquiry. See our B2B, Import & Export Enquiries section above.
Related Product Categories
SDO Pharma works across several pharmaceutical and healthcare product categories for business customers.